Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Katarzyna Bukato
Observed name:
K. Bukato
Institution:
Adamed (Poland)
Observed institutions:
Adamed (Poland),
Gdańsk Medical University
ORCID:
0000-0002-4749-9625
Observed ORCID:
0000-0002-4749-9625
OpenAlex ID:
A5079043540
Endogenous estrogen metabolites as oxidative stress mediators and endometrial cancer biomarkers
2024
·
Katarzyna Bukato
, Tomasz Kostrzewa
, et al.
·
Cell Communication and Signaling
·
51
PDF
Breastfeeding vs. Formula Feeding and Maternal Sexuality among Polish Women: A Preliminary Report
2023
·
Anna Weronika Szablewska
, Anna Michalik
, et al.
·
Healthcare
·
12
PDF
Novel engineered TRAIL‐based chimeric protein strongly inhibits tumor growth and bypasses TRAIL resistance
2019
·
Piotr Rozga
, Damian Kloska
, et al.
·
International Journal of Cancer
·
12
AD-O53.2—a novel recombinant fusion protein combining the activities of TRAIL/Apo2L and Smac/Diablo, overcomes resistance of human cancer cells to TRAIL/Apo2L
2014
·
Jerzy S. Pieczykolan
, Konrad Kubiński
, et al.
·
Investigational New Drugs
·
11
Abstract 2773: AD-O56.9: A fusion of TRAIL/Apo2L with a membrane disrupting peptide as a novel anticancer therapeutic
2014
·
Bartlomiej Maciej Zerek
, Michal Szymanik
, et al.
·
Cancer Research
·
1
Design and biological evaluation of triagonist GLP-1R/GCGR/GIPR peptides as potential therapeutic agents for diabetes and obesity
2026
·
Iwona Kalinowska
, Alicja Gawalska
, et al.
·
RSC Medicinal Chemistry
PDF
135 AD-O64.3: IFN-γ–TRAIL fusion protein. Use of two independent signaling pathways for a strong synergistic antitumor effect
2014
·
B. Zerek
, J.S. Pieczykolan
, et al.
·
European Journal of Cancer
519 AD-O53.2 – novel biological anticancer therapeutic agent with a dual mechanism of action
2014
·
K. Poleszak
, J. Pieczykolan
, et al.
·
European Journal of Cancer
367 Induction of apoptosis and inhibition of angiogenesis by novel fusion protein – AD-O54.9 as a new preclinical strategy in cancer treatment
2014
·
P. Rozga
, B. Zerek
, et al.
·
European Journal of Cancer
467 Two in one – Delivery of apoptotic signal into cancer cells by new class of TRAIL derived, fusion protein
2014
·
S.D. Pawlak
, B.M. Zerek
, et al.
·
European Journal of Cancer
Abstract 3796: Biochemical and biophysical characterization of AD-O51.4 a novel anticancer biological therapeutic agent with dual mechanism of action
2014
·
Sebastian D. Pawlak
, Jerzy S. Pieczykolan
, et al.
·
Cancer Research
Abstract 4471: AD-O64.4 - a novel bioconjugate for tumor-targeted drug delivery
2014
·
Wojciech Strozek
, Anna Pieczykolan
, et al.
·
Cancer Research
Abstract 2276: Induction of apoptosis and inhibition of angiogenesis by novel fusion protein - AD-O54.9 as a new preclinical strategy in cancer treatment
2014
·
Piotr Rózga
, Jerzy Pieczykolan
, et al.
·
Cancer Research
Show more works
View as search
Works count:
13
Citation count:
87
H-index:
4
I10-index:
4
Year
Topic
Type
